N-Methyl-1H-indol-7-amine hydrochloride

Catalog No.: 
ACBFYU358
CAS No.: 
2060033-76-1
Molecular Formula: 
C9H11ClN2
Molecular Weight: 
182.65
N-Methyl-1H-indol-7-amine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$273.00InquiryInquiry
100mg95%$397.00InquiryInquiry
250mg95%$560.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-1H-indol-7-amine hydrochloride
IUPAC NameN-methyl-1H-indol-7-amine hydrochloride
MDL No.MFCD30497739
Molecular FormulaC9H11ClN2
Molecular Weight182.65
SMILESCNC1=CC=CC2=C1NC=C2.[H]Cl
InChI KeyNLAWDGQAOIWYLB-UHFFFAOYSA-N
SynonymN-methyl-1H-indol-7-amine hydrochloride;1H-Indol-7-amine, N-methyl-, hydrochloride (1:1)
CAS No.2060033-76-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBFYU358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCSTR309 route compound structure diagram
    ACCSTR3095192-04-1In Stock
  4. Then
  5. ACBFYU358 route product structure diagram
    ACBFYU3582060033-76-1
Inquiry

2. ACBFYU358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACCSTR309 route compound structure diagram
    ACCSTR3095192-04-1In Stock
  4. Then
  5. ACBFYU358 route product structure diagram
    ACBFYU3582060033-76-1
Inquiry

3. ACBFYU358 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBFYU358 route product structure diagram
    ACBFYU3582060033-76-1
Inquiry

Comments (0)